MNTK

Montauk is a real, 30-year RNG operator with 11 RNG projects and positive operating cash flow ($30.3M), so this is not a distressed shell. But the earnings trajectory is unambiguously deteriorating: net income has fallen from $35.2M (FY2022) to $14.9M, $9.73M, and now just $1.75M in FY2025 — down 82% year-over-year — while operating income cratered 94.7% to $852K, leaving a 0.5% operating margin and 0.7% ROE. Revenue has been dead flat at ~$176M for three straight years, so the profit erosion is a margin/cost story, not a growth story. The $0.01 diluted EPS produces a nonsensical 169x P/E; there is no earnings support for the current price.

The balance sheet is where risk is building. The company is funding an aggressive growth capex cycle — $117M of capex in FY2025 (+87%), roughly 4x operating cash flow — by levering up: long-term debt jumped 188% to $126M while cash was cut nearly in half to $23.8M (-47.9%) and current assets fell 35%. Management's own MD&A flags that impairment charges ($3.2M booked in 2025) could jeopardize compliance with Credit Agreement financial covenants, and that an event of default could accelerate the entire facility. That is the key overhang: a business earning $1.75M net is spending heavily and drawing down liquidity into a covenanted debt structure.